ADIPOQ and Insulin resistance: Because adiponectin is a critical adipokine that increases insulin sensitivity and reduces tissue inflammation (Whitehead et al. 2006), any factor that suppresses its release could lead to insulin resistance and increased susceptibility to development of metabolic syndrome.